PMC9618854_01
Changes in the electrocardiogram. (A) after admission; (B) on day twelve of admission.
fphar-13-900701-g001.jpg
PMC9618854_01_fphar-13-900701-g001.jpg
F1
Electrocardiogram (ECG) showed a low T-wave that was flat and inverted in leads II and III, and aVF (Figure 1). The ECG changes before and after the treatment are shown in Figure 1.
The red arrow represents the start of the use of glucocorticoids. The green arrow represents the levothyroxine administration. The numbered green arrows indicate the administered doses as follows: 1, 25 mg/d; 2, 50 mg/d; 3, 100 mg/d; 4, 125 mg/d. The following are also shown: (A) thyroid-stimulating hormone, free triiodothyronine, and, free thyroxine; (B) thyroid peroxidase antibody and thyroglobulin antibodies; (C) PO2, FiO2, and oxygenation index; (D) white blood cell count and NE%.
fphar-13-900701-g002.jpg
PMC9618854_01_fphar-13-900701-g002.jpg
F2
The fraction of inspired oxygen improvement, as well as white blood cell count throughout the therapy process are shown in Figure 2.
A comparison of pulmonary computed tomography (A) before glucocorticoids administration, (B) after weaning, and (C) before discharge.
fphar-13-900701-g003.jpg
PMC9618854_01_fphar-13-900701-g003.jpg
F3
The CT changes in the patient's lungs are shown in Figure 3.